Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ACS Chemical Biology|June 9, 2026
Generation of Infectious Prions Amenable to Site-Specific Click ChemistryRyan G Campbell, Jolene N Iseler, Abigail M Schwind, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Generation of Infectious Prions Amenable to Site-specific Click ChemistryRyan G Campbell, Jolene N Iseler, Abigail M Schwind, et al.
Purinergic Signalling|June 10, 2022
Fluorescent A<sub>2A</sub> and A<sub>3</sub> adenosine receptor antagonists as flow cytometry probesKiran S Toti, Ryan G Campbell, Hobin Lee, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Selective A<sub>3</sub> Adenosine Receptor Antagonist Radioligand for Human and Rodent SpeciesR Rama Suresh, Zhan-Guo Gao, Veronica Salmaso, et al.
European Journal of Medicinal Chemistry|February 13, 2022
Interaction of A<sub>3</sub> adenosine receptor ligands with the human multidrug transporter ABCG2Biebele Abel, Megumi Murakami, Dilip K Tosh, et al.
RSC Advances|April 28, 2022
Convergent synthesis of 2-thioether-substituted (<i>N</i>)-methanocarba-adenosines as purine receptor agonistsR Rama Suresh, Russell B Poe, Baorui Lin, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Biochemistry|February 28, 2019
Mechanism of 6-Hydroxynicotinate 3-Monooxygenase, a Flavin-Dependent Decarboxylative Hydroxylase Involved in Bacterial Nicotinic Acid DegradationKent D Nakamoto, Scott W Perkins, Ryan G Campbell, et al.
ACS Pharmacology & Translational Science|October 21, 2022
Effects of Purinergic Receptor Deletion or Pharmacologic Modulation on Pulmonary Inflammation in MiceGregory S Whitehead, Tadeusz P Karcz, Dilip K Tosh, et al.
European Journal of Medicinal Chemistry|August 10, 2023
Structure activity relationships of 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> serotonin receptor antagonists: N<sup>6</sup>, C2 and 5'-Modified (N)-methanocarba-adenosine derivativesDilip K Tosh, Maggie M Calkins, Marko S Ivancich, et al.
Pageof 2